🔎 Trials Near Me

홈 › 흑색종 › 펜실베이니아

펜실베이니아의 흑색종 임상 시험

흑색종 관련 연구 47개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.

펜실베이니아의 도시

공식 연구 텍스트(영어)

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Thomas Jefferson University Hospital, Philadelphia
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • St. Luke's University Health Network, Easton
  • Penn State Health Milton South Hershey Medical Center, Hershey
  • Fox Chase Cancer Center, Philadelphia
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06246916

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
피험자 모집 중2상
25세 이하 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07621614

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  • Allegheny Health Network, Pittsburgh
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT05727904

Pan-tumor MRD Study

  • Lancaster General Hospital (UPenn), Lancaster
  • Guthrie Foundation, Sayre
  • Cancer Care Associates of York (CCAY), York
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • Fox Chase Cancer Center - East Norriton Hospital Outpatient Center, East Norriton
  • UPMC Hillman Cancer Center Erie, Erie
  • 외 4개
피험자 모집 중3상
75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  • University of Pennsylvania, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT04752826

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of Pennsylvania, Philadelphia
  • WellSpan Medical Oncology & Hematology at York Cancer Center, York
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

  • University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07070232

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • 외 7개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital of Philadelphia, Philadelphia
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
피험자 모집 중1/2상
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

Project: Every Child for Younger Patients With Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Children's Hospital, Hershey
  • 외 4개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

Investigating Real-Time Immunotherapy Symptoms Study

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT07280715

Tebentafusp-tebn With LDT in Metastatic UM

  • Thomas Jefferson University, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT06626516

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

  • Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 16. 업데이트됨 · NCT06060613

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT04114136

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 ~ 70세 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05361174

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT04658303

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

  • Fox Chase Cancer Center, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 ~ 90세 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT05655312

Evaluation of Hypoxia in Primary Melanoma

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT06831071

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT03947385

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

  • Fox Chase Cancer Center, Philadelphia
피험자 모집 중초기 1상
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT05498792

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
  • 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • Jefferson Health Honickman Center, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT06413680

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

  • UPenn, Philadelphia
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT06624644

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT06326411

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 16. 업데이트됨 · NCT07223424

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중초기 1상
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT06216938

A Study of VET3-TGI in Patients With Solid Tumors

  • UPMC- Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 7. 업데이트됨 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Thomas Jefferson University, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • WellSpan Medical Oncology and Hematology, Chambersburg
  • 외 13개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

  • Thomas Jefferson University Medical Oncology Clinic, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT05549297

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

  • St. Luke's University Health Network, Easton
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT04903119

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 26. 업데이트됨 · NCT06599619

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • Penn State Cancer Institute, Hershey
  • Fox Chase Cancer Center 333 Cottman Avenue, Philadelphia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 12. 17. 업데이트됨 · NCT03567889

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.